Siga Technologies (SIGA) Accumulated Expenses (2010 - 2025)
Siga Technologies' (SIGA) quarterly Accumulated Expenses came in at $6.5 million in Q4 2025, up 15.6% on a YoY basis from $5.6 million in Q4 2024, and down 31.17% quarter-over-quarter from $9.5 million in Q3 2025.
Analysis
Siga Technologies (SIGA) Accumulated Expenses (2010 - 2025) Analysis & Trends
Siga Technologies (SIGA) has reported Accumulated Expenses for 16 consecutive years, with $6.5 million the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Expenses rose 15.6% year-over-year to $6.5 million; the trailing twelve-month figure through Dec 2025 stood at $6.5 million (up 15.6% YoY), and the FY2025 full-year result was $6.5 million, up 15.6% from the prior year.
- Accumulated Expenses declined to $6.5 million in Q4 2025 per SIGA's latest filing, from $9.5 million in the prior quarter.
- Across five years, Accumulated Expenses topped out at $30.1 million in Q3 2023 and bottomed at $4.7 million in Q1 2022.
- Historically, Accumulated Expenses has averaged $10.7 million across 5 years, with a median of $8.1 million in 2021.
- The sharpest annual moves came in 2023 and 2024: Accumulated Expenses jumped 243.86% in 2023, then plunged 76.15% in 2024.
- Over 5 years, Accumulated Expenses stood at $9.3 million in 2021, then tumbled by 31.87% to $6.3 million in 2022, then surged by 61.51% to $10.2 million in 2023, then sank by 44.61% to $5.6 million in 2024, then advanced by 15.6% to $6.5 million in 2025.
- According to Business Quant data, Accumulated Expenses over the past three periods registered $6.5 million, $9.5 million, and $7.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 643.26 Bn | 622.50 Bn | 17.26 Bn |
| 2 | AbbVie | 443.31 Bn | 436.74 Bn | 12.70 Bn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.46 Bn | 258.77 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.33 Bn | 44.95 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.79 Bn | 43.79 Bn | - |
| 8 | Incyte | 25.23 Bn | 20.69 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.67 Bn | 19.01 Bn | 683.80 Mn |
| 10 | Siga Technologies | 220.19 Mn | 65.22 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 6.52 Mn |
| Sep 30, 2025 | 9.47 Mn |
| Jun 30, 2025 | 7.11 Mn |
| Mar 31, 2025 | 16.23 Mn |
| Dec 31, 2024 | 5.64 Mn |
| Sep 30, 2024 | 7.18 Mn |
| Jun 30, 2024 | 6.53 Mn |
| Mar 31, 2024 | 6.12 Mn |
| Dec 31, 2023 | 10.18 Mn |
| Sep 30, 2023 | 30.13 Mn |
| Jun 30, 2023 | 17.89 Mn |
| Mar 31, 2023 | 16.00 Mn |
| Dec 31, 2022 | 6.30 Mn |
| Sep 30, 2022 | 15.89 Mn |
| Jun 30, 2022 | 14.84 Mn |
| Mar 31, 2022 | 4.65 Mn |
| Dec 31, 2021 | 9.25 Mn |
| Sep 30, 2021 | 8.98 Mn |
| Jun 30, 2021 | 7.30 Mn |
| Mar 31, 2021 | 7.06 Mn |